Nature Chemical BiologyBiochemistryPeer-reviewed journal article
A small molecule VHL molecular glue degrader for cysteine dioxygenase 1
A. Tutter, D. Buckley, A. A. Golosov, X. Ma, W. Shu, D. J. Mckay, V. Darsigny, D. Dovala, R. Beckwith, J. Solomon, P. Rao, L. Xu, A. Fazal, A. Lingel, C. Wartchow, J. S. Cobb, A. Hachey, J. Tullai, G. A. Michaud
Abstract
The Von Hippel-Lindau Tumor Suppressor gene product (pVHL) is an E3 ligase substrate receptor that binds proline-hydroxylated HIF1-, leading to its ubiquitin-dependent degradation. By using protein arrays, we identified a small molecule that binds the HIF1- binding pocket on pVHL and functions as a molecular glue degrader of the neosubstrate cysteine dioxygenase (CDO1) by recruiting it into the VHL-cullin-ring E3 ligase complex and leading to its selective degradation. The CDO1 binding region involved in VHL recruitment was characterized through a combination of mutagenesis and protein-protein docking coupled with molecular dynamics-based solvation analysis. The X-ray structure of the ternary complexes of VHL, CDO1, and degrader molecules confirms the binding region prediction and provides atomic insights into key molecular glue interactions.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Reprogramming VHL with molecular glues enables selective degradation of caspase-2
Jianzhong Hu, Weixian Deng, … Jaeki Min·bioRxiv·Aug 17, 2026
- VHL inhibitor binding increases intracellular level of VHL
- Linker-rigidified VHL homodimerizers convert degraders into stabilizers of non-ubiquitinable ternary complexes
Charlotte Crowe, Alessandra Salerno, … Alessio Ciulli·bioRxiv·Nov 18, 2025
- Structure-guided design and optimization of covalent VHL-targeted sulfonyl fluoride PROTACs
Rishi R. Shah, Elena De Vita, … Edward W. Tate·Journal of Medicinal ChemistryPeer-reviewed·Mar 13, 2024
- The E3 ubiquitin-protein ligase MDM2 is a novel interactor of the von Hippel-Lindau tumor suppressor
A. Falconieri, G. Minervini, … S. C. E. Tosatto·bioRxiv·Apr 28, 2020
- Rapid and direct control of target protein levels with VHL-recruiting dTAG molecules
B. Nabet, F. M. Ferguson, … N. S. Gray·bioRxiv·Mar 13, 2020